figures data base

Here is the data used to produce the presented figures of the article: "The rise of health biotechnology research in Latin America: A scientometric analysis of health biotechnology production and impact in Argentina, Brazil, Chile, Colombia, Cuba and Mexico

Main data base

Here is the main database of the paper production by the six Latin American countries studied in the article: "The rise of health biotechnology research in Latin America: A scientometric analysis of health biotechnology production and impact in Argentina, Brazil, Chile, Colombia, Cuba and Mexico". The information is organized in different tabs. Each tab is identified with a country name

China’s strength of collaboration with other top producers of stem cell research, 2006–2010.

<p>Shown is the strength of China’s collaboration (indicated by Salton’s measure – the larger the number, the stronger the mutual strength of the collaboration between the two countries) with the other top 10 global producers of stem cell research, as well as for comparison – the Stem Cell Network Asia Pacific (SNAP) members, Hong Kong, and emerging economies India and Brazil.</p

Number of publications in health biotechnology per million inhabitants, 2001–2015.

<p>Source: WOS data and United Nations Department of Economic and Social Affairs data [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0191267#pone.0191267.ref052" target="_blank">52</a>,<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0191267#pone.0191267.ref071" target="_blank">71</a>].</p

Sino-Canadian Collaborations in Stem Cell Research: A Scientometric Analysis

<div><p>Background</p><p>International collaboration (IC) is essential for the advance of stem cell research, a field characterized by marked asymmetries in knowledge and capacity between nations. China is emerging as a global leader in the stem cell field. However, knowledge on the extent and characteristics of IC in stem cell science, particularly China’s collaboration with developed economies, is lacking.</p> <p>Methods and Findings</p><p>We provide a scientometric analysis of the China–Canada collaboration in stem cell research, placing this in the context of other leading producers in the field. We analyze stem cell research published from 2006 to 2010 from the Scopus database, using co-authored papers as a proxy for collaboration. We examine IC levels, collaboration preferences, scientific impact, the collaborating institutions in China and Canada, areas of mutual interest, and funding sources. Our analysis shows rapid global expansion of the field with 48% increase in papers from 2006 to 2010. China now ranks second globally after the United States. China has the lowest IC rate of countries examined, while Canada has one of the highest. China–Canada collaboration is rising steadily, more than doubling during 2006–2010. China–Canada collaboration enhances impact compared to papers authored solely by China-based researchers This difference remained significant even when comparing only papers published in English.</p> <p>Conclusions</p><p>While China is increasingly courted in IC by developed countries as a partner in stem cell research, it is clear that it has reached its status in the field largely through domestic publications. Nevertheless, IC enhances the impact of stem cell research in China, and in the field in general. This study establishes an objective baseline for comparison with future studies, setting the stage for in-depth exploration of the dynamics and genesis of IC in stem cell research.</p> </div

Subfields of health biotechnology in the 2001–2015 period with specialization indices > 1.

<p>Subfields of health biotechnology in the 2001–2015 period with specialization indices > 1.</p

Keywords used to search WOS for health biotechnology.

<p>Keywords used to search WOS for health biotechnology.</p

Number of papers in health biotechnology by selected countries, 2001–2015.

<p>Source: WOS data [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0191267#pone.0191267.ref052" target="_blank">52</a>].</p

Top 55 publishers in health biotechnology, 2001–2015.

<p>Logarithm scale. Source: WOS data [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0191267#pone.0191267.ref052" target="_blank">52</a>].</p

Rate of domestic collaboration in health biotechnology, 2001–2015.

<p>Source: WOS data [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0191267#pone.0191267.ref052" target="_blank">52</a>].</p